The use of compounds in the treatment of autoimmune and inflammatory diseases or conditions, pharmaceutical compositions containing such compounds and to methods for identifying compounds for use in the treatment of such diseases or conditions.Utilisation d'un inhibiteur de bromodomaine dans le traitement de maladies ou de pathologies auto-immunes ou inflammatoires, compositions pharmaceutiques contenant de tels composés et méthodes d'identification de composés de telles maladies et pathologies.